Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Hold Parameters on Likely Cardiovascular Depressant Medications

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Hackensack University Medical Center Identifier:
First received: September 7, 2007
Last updated: February 1, 2014
Last verified: February 2014

This pilot study is being pursued to observe whether certain medications are given to patients within a timeframe where their being given could play a part in a critical event in the management of the patient.

There are general rules about when it would be appropriate for these types of medications not to be given. However, it is not current standard practice for the criteria to be put in place without the expressed wishes of the ordering physician or their agent.

Research Question:

Can the administration of cardio-depressant medications be documented as a significant risk factor for hypotensive or bradycardic events?


Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Hold Parameters on Likely Cardiovascular Depressant Medications (HOLD)

Further study details as provided by Hackensack University Medical Center:

Study Start Date: August 2006
Estimated Primary Completion Date: August 2006 (Final data collection date for primary outcome measure)

Genders Eligible for Study:   Both

Inclusion Criteria:

  • Serial evaluation of the first 50 documented events of Code Blue or call to Rapid Response Team involving hypotension, bradycardia or asystole in the adult inpatient population events beginning January 1, 2006.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00527709

United States, New Jersey
Hackensack University Medical Center
Hackensack, New Jersey, United States, 07601
Sponsors and Collaborators
Hackensack University Medical Center
Principal Investigator: Amit Tailor, MD, MBA Hackensack University Medical Center
  More Information

No publications provided

Responsible Party: Hackensack University Medical Center Identifier: NCT00527709     History of Changes
Other Study ID Numbers: 06.01.025
Study First Received: September 7, 2007
Last Updated: February 1, 2014
Health Authority: United States: Institutional Review Board processed this record on March 03, 2015